MX Mexiko City Moreno-Sanchez R: Difference between revisions
From Bioblast
No edit summary |
No edit summary  |
||
(2 intermediate revisions by the same user not shown) | |||
Line 3: | Line 3: | ||
Instituto Nacional de CardiologĂa | Instituto Nacional de CardiologĂa | ||
|address=Juan Badiano No. 1 | |||
Col. Seccion 16, 14080 | |||
|city=Mexico City | |city=Mexico City | ||
|country=Mexico | |country=Mexico | ||
| | |Team previous=Moreno-Sanchez Rafael, Rodriguez-Enriquez Sara | ||
|Status=O2k 2015-2022 | |||
|Status=O2k 2015- | |||
}} | }} |
Latest revision as of 08:37, 7 September 2022
MX Mexiko City Moreno-Sanchez R
O2k-Network Lab | Departamento de BioquĂmica
Instituto Nacional de CardiologĂa |
---|---|
Address | Juan Badiano No. 1
Col. Seccion 16, 14080, |
City | Mexico City |
State/Prov | |
Country | Mexico |
Weblink | |
Contact | |
Team | |
Team previous | Moreno-Sanchez Rafael, Rodriguez-Enriquez Sara |
Status | O2k 2015-2022 |
Oroboros Events | |
Topics |
O2k-Publications
Published | Reference | |
---|---|---|
Robledo-Cadena 2020 Pharmaceuticals (Basel) | 2020 | Robledo-Cadena DX, Gallardo-PĂ©rez JC, DĂĄvila-Borja V, Pacheco-VelĂĄzquez SC, Belmont-DĂaz JA, Ralph SJ, Blanco-Carpintero BA, Moreno-SĂĄnchez R, RodrĂguez-EnrĂquez S (2020) Non-steroidal anti-inflammatory drugs increase cisplatin, paclitaxel, and doxorubicin efficacy against human cervix cancer cells. Pharmaceuticals (Basel) 13:463. |
Rodriguez-Enriquez 2019 Toxicol Appl Pharmacol | 2019 | RodrĂguez-EnrĂquez S, Pacheco-VelĂĄzquez SC, MarĂn-HernĂĄndez Ă, Gallardo-PĂ©rez JC, Robledo-Cadena DX, HernĂĄndez-ResĂ©ndiz I, GarcĂa-GarcĂa JD, Belmont-DĂaz J, LĂłpez-Marure R, HernĂĄndez-Esquivel L, SĂĄnchez-Thomas R, Moreno-SĂĄnchez R (2019) Resveratrol inhibits cancer cell proliferation by impairing oxidative phosphorylation and inducing oxidative stress. Toxicol Appl Pharmacol 370:65-77. |
Pacheco-Velazquez 2018 Mol Pharm | 2018 | Pacheco-VelĂĄzquez SC, Robledo-Cadena DX, HernĂĄndez-ResĂ©ndiz I, Gallardo-PĂ©rez JC, Moreno-SĂĄnchez R, RodrĂguez-EnrĂquez S (2018) Energy metabolism drugs block triple negative breast metastatic cancer cell phenotype. Mol Pharm 15:2151-64. |
Hernandez-Resendiz 2018 J Cell Physiol | 2018 | HernĂĄndez-ResĂ©ndiz I, Gallardo-PĂ©rez JC, LĂłpez-Macay A, Robledo-Cadena DX, GarcĂa-Villa E, Gariglio P, Saavedra E, Moreno-SĂĄnchez R, RodrĂguez-EnrĂquez S (2018) Mutant p53R248Q downregulates oxidative phosphorylation and upregulates glycolysis under normoxia and hypoxia in human cervix cancer cells. J Cell Physiol 234:5524-36. |
O2k-Abstracts
update please